K. Seio et al. / Bioorg. Med. Chem. Lett. 22 (2012) 2470–2473
2473
9. Song, Q.; Jones, R. A. Tetrahedron Lett. 1999, 40, 4653.
10. Beaucage, S. L.; Caruthers, M. H. Tetrahedron Lett. 1981, 22, 1859.
11. Michael, L.; Andreas, W. PCT Int. WO 2,006,116,476, 2006.
oligonucleotides such as nucleic acids drug and oligonucleotide
probes.
12. Hayakawa, Y.; Kawai, R.; Hirata, A.; Sugimoto, J.; Kataoka, M.; Sakakura, A.;
Hirose, M.; Noyori, R. J. Am. Chem. Soc. 2001, 123, 8165.
13. Welz, R.; Müller, S. Tetrahedron Lett. 2002, 43, 795.
Acknowledgments
14. Vargeese, C.; Carter, J.; Yagge, J.; Krivjansky, S.; Settle, A.; Kropp, E.; Peterson,
K.; Pieken, W. Nucleic Acids Res. 1998, 26, 1046.
15. (a) Wang, Z.; Siwkowski, A.; Lima; F, W.; Olsen, P.; Ravikumar, V. T. Bioorg. Med.
Chem. 2006, 14, 5049; (b) Lackey, G. J.; Mitra, D.; Somoza, M. M.; Cerrina, F.;
Damha, M. J. J. Org. Chem. 2009, 131, 8496; (c) Op de Beeck, M.; Madder, A. J.
Am. Chem. Soc. 2011, 133, 796.
16. Griffey, R. H.; Monia, B. P.; Cummins, L. L.; Freier, S.; Greig, M. J.; Guinosso, C. J.;
Lesnik, E.; Manalili, S. M.; Mohan, V.; Owens, S.; Ross, B. R.; Sasmor, H.;
Wancewicz, E.; Weiler, K.; Wheeler, P. D.; Cook, P. D. J. Med. Chem. 1996, 39,
5100.
This study was supported by a grant-in-aid for Scientific Re-
search from the Ministry of Education, Culture, Sports, Science
and Technology, Japan, and Adaptable and Seamless Technology
Transfer Program of JST. The authors thank center for Advanced
Materials Analysis (Suzukakedai), Technical Department, Tokyo
Institute of Technology, for MALDI-TOF mass analysis.
References and notes
17. (a) Ohkubo, A.; Noma, Y.; Aoki, K.; Tsunoda, H.; Seio, K.; Mitsuo, S. J. Org. Chem.
2009, 74, 2817; (b) General procedure for the deprotection of Uabcm modified
oligonucleotides:
1. (a) Prakash, T. P.; Bhat, B. Curr. Top. Med. Chem. 2007, 7, 641; (b) Prakash, T. P.;
Kawasaki, A. M.; Wancewicz, E. V.; Shen, L.; Monia, B. P.; Ross, B. S.; Bhat, B.;
Manoharan, M. J. Med. Chem. 2008, 51, 2766; (c) Oeda, Y.; Iijima, Y.; Taguchi, H.;
Ohkubo, A.; Seio, K.; Sekine, M. Org. Lett. 2009, 11, 5582; (d) Sekine, M.; Oeda,
Y.; Iilima, Y.; Taguchi, H.; Ohkubo, A.; Seio, K. Org. Biomol. Chem. 2010, 9, 210.
2. Buchini, S.; Leumaa, C. J. Eur. J. Org. Chem. 2006, 14, 3152.
3. Bramsen, J. B.; Laursen, M. B.; Nielsen, A. F.; Hansen, T. B.; Bus, C.; Langkjær, N.;
Babu, B. R.; Højland, T.; Abramov, M.; Van Aerschot, A.; Odadzic, D.; Smicius, R.;
Haas, J.; Andree, C.; Barman, J.; Wenska, M.; Srivastava, P.; Zhou, C.;
Honcharenko, D.; Hess, S.; Müller, E.; Bobkov, G. V.; Mikhailov, S. N.; Fava, E.;
Meyer, T. F.; Chattopadhyaya, J.; Zerial, M.; Engels, J. W.; Herdewijn, P.; Wengel,
J.; Kjems, J. Nucleic Acids Res. 2009, 37, 2867.
An acCm-loaded CPG solid phase support (1
lmol) having a succinyl linker was
treated with 3% TCA in CH2Cl2 (1 mL) for 1 min at room temperature. After
washing [CH3CN 1 mL ꢀ 3] and drying under reduced pressure, the
condensation of the acCm-loaded solid phase support with phosphoramidite
unit 5 was performed as follows: (1) coupling [phosphoramidite unit 5 (19 mg,
20
(400
[phosphoramidite unit 5 (19 mg, 20
(10 mg, 80 mol) in dry CH3CN (400
l
mol) and 4,5-dicyanoimidazole (DCI) (10 mg, 80
L)] for 40 min, (2) washing [CH3CN 1 mL ꢀ 3], (3) drying, (4) coupling
mol) and 4,5-dicyanoimidazole (DCI)
L)] for 40 min, (5) washing [CH3CN
lmol) in dry CH3CN
l
l
l
l
1 mL ꢀ 3], (6) drying, (7) capping [2.5% phenoxyacetic anhydride and 5% 1-
methylimidazole in THF-pyridine 1 mL] for 5 min, (8) washing [CH3CN
1 mL ꢀ 3], (9) oxidation [0.02 M I2 in THF–pyridine–H2O 1 mL] for 1 min,
(10) washing [CH3CN 1 mL ꢀ 3], (11) drying, (12) 3% TCA in CH2Cl2, (13)
washing [CH3CN 1 mL ꢀ 3], (12) drying. Subsequently, the CPG solid phase
support was treated with 10% DBU in CH3CN (1 mL) for 1 min. After washing
[CH3CN 1 mL ꢀ 3] and drying under reduced pressure, the solid phase support
was treated with 28% aqueous ammonia at room temperature for 24 h. The
4. Yamada, T.; Okaniwa, N.; Saneyoshi, H.; Ohkubo, A.; Nagata, T.; Aoki, Y.;
Takeda, S.; Sekine, M. J. Org. Chem. 2011, 76, 3042.
5. Saneyoshi, H.; Seio, K.; Sekine, M. J. Org. Chem. 2005, 70, 10453.
6. (a) Korshun, V. A.; Stetsenko, D. A.; Gait, M. J. J. Chem. Soc., Perkin Trans. 1 2002,
1092; (b) Misra, A.; Dwivedi, P.; Shahid, M. Russ. J. Bioorg. Chem. 2009, 35, 62;
(c) Dioubankova, N. N.; Malakahov, A. D.; Shenkarev, Z. O.; Korshun, V. A.
Tetrahedron 2004, 60, 4617.
7. Seio, K.; Tawarada, R.; Sasami, T.; Serizawa, M.; Ise, M.; Ohkubo, A.; Sekine, M.
Bioorg. Med. Chem. 2009, 17, 7275.
8. (a) Prhavc, M.; Lesnik, A. E.; Mohan, V.; Manoharan, M. Tetrahedron Lett. 2001,
42, 8777; (b) Pattanaek, R.; Sethaphong, L.; Pan, C.; Prhavc, M.; Prakash, T. P.;
Manoharam, M.; Egli, M. J. Am. Chem. Soc. 2004, 126, 15006.
CPG support was removed by filtration and washed with H2O (500
filtrate was purified by reversed phase HPLC to give UabcmCm 7 in 35% yield.
abcmCm 7; ESI-mass m/z Mass calcd for [C24H36N7O14P+H]+ 678.2, found 678.5.
lL ꢀ 3). The
U
18. Teplova, M.; Wallace, S. T.; Tereshko, V.; Minasov, G.; Symons, A. M.; Cook, P.
D.; Manoharan, M.; Egli, M. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 14240.